Akeso

This study is testing if an immunotherapy drug called AK104, given before and after surgery, works better than standard chemotherapy for people with a specific type of colon cancer that can be surgically removed. It will involve about 386 adults with stage IIB-III colon cancer th…

This study is testing whether an investigational drug called AK139 can help control moderate to severe asthma. It will involve about 160 adults whose asthma is not fully controlled. Researchers will measure if the drug improves lung function and reduces airway inflammation, while…

This is a first-in-human study to check if a new drug called AK152 is safe and how it behaves in the body. It will involve 108 healthy volunteers and people with early Alzheimer's disease. The main goal is to find the right dose and understand side effects before testing if it he…

This study is testing whether a new two-drug combination (AK112 and VG2025) is safe and effective for people with advanced colorectal cancer that has spread to the liver and has stopped responding to standard treatments. It will enroll about 72 adults to first find the safest dos…

This study is testing an investigational drug called AK112 for people with advanced non-squamous lung cancer. It is for patients whose cancer has a specific genetic change and has stopped responding to standard targeted pills (TKIs). The main goal is to see if AK112 can shrink tu…

This study is testing whether giving the immunotherapy drug AK104 as a simple injection under the skin works as well as giving it through an IV when combined with standard chemotherapy for advanced stomach cancer. The trial will enroll 422 people with advanced stomach or gastroes…

This study is testing whether an investigational injection called AK139 can safely reduce moderate to severe seasonal allergy symptoms like sneezing and a runny nose. About 111 adults with a history of poorly controlled seasonal allergies will receive either AK139 or a placebo sh…